Thomas E. Hudson
Impact in
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
- Renal Diseases and Glomerulopathies
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
-
- Immune Response and Inflammation 6
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 4
- Phagocytosis and Immune Regulation 2
-
- Renal and related cancers 3
- Epigenetics and DNA Methylation 1
- Co-authors
- Jeremy S. Duffield (5 shared papers)Brian T. Nowlin (4 shared papers)Shuei‐Liong Lin (4 shared papers)Andrew P. McMahon (2 shared papers)Joseph V. Bonventre (3 shared papers)Benjamin D. Humphreys (1 shared paper)M. Todd Valerius (1 shared paper)Akio Kobayashi (1 shared paper)
- Journals
- The FASEB Journal (2 papers)PLoS ONE (2 papers)Proceedings of the National Academy of Sciences (2 papers)The Journal of Immunology (2 papers)Circulation (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Thomas E. Hudson
14 papers receiving 2.0k citations
Thomas E. Hudson's Hit Papers
Peers
Comparison fields: 5 of 93
- Nephrology 482
- Immunology 405
- Genetics 169
- Molecular Biology 897
- Pulmonary and Respiratory Medicine 333
Countries citing papers authored by Thomas E. Hudson
This map shows the geographic impact of Thomas E. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Hudson more than expected).
Fields of papers citing papers by Thomas E. Hudson
This network shows the impact of papers produced by Thomas E. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Hudson. The network helps show where Thomas E. Hudson may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Hudson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis Hit paper breakdown → | 2009 | 1132 |
| 2 | 2010 | 353 | |
| 3 | 2010 | 135 | |
| 4 | 2010 | 119 | |
| 5 | 2018 | 74 | |
| 6 | 2013 | 68 | |
| 7 | 2014 | 65 | |
| 8 | 2016 | 42 | |
| 9 | 2015 | 39 | |
| 10 | 2010 | 18 | |
| 11 | 2015 | 15 | |
| 12 | 2016 | 3 | |
| 13 | Ties that bind. | 1997 | 1 |
| 14 | New law on advance directives. | 1991 | 1 |
About Thomas E. Hudson
Thomas E. Hudson is a scholar working on Immunology, Molecular Biology, Infectious Diseases, Epidemiology and Surgery, having authored 14 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers), Renal and related cancers (3 papers), Tuberculosis Research and Epidemiology (2 papers), Autophagy in Disease and Therapy (2 papers), Phagocytosis and Immune Regulation (2 papers) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Nephrology (482 citations), Immunology (405 citations), Genetics (169 citations), Molecular Biology (897 citations) and Pulmonary and Respiratory Medicine (333 citations). Thomas E. Hudson has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Jeremy S. Duffield, Brian T. Nowlin, Shuei‐Liong Lin, Andrew P. McMahon, Joseph V. Bonventre, Benjamin D. Humphreys, M. Todd Valerius, Akio Kobayashi, Bing Li and Mark T. Orr. Their work appears in journals such as The FASEB Journal, PLoS ONE, Proceedings of the National Academy of Sciences, The Journal of Immunology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.